We are excited to announce that Biocytogen will be attending Tumour Models Summit San Francisco. As funding cuts by the NIH and changes in FDA regulations are reshaping the landscape of oncology, it is more important than ever for industry leaders to stay ahead of the curve. Join us in discovering breakthrough technologies and modalities that can help navigate this pivotal shift. Stop by to meet our team and learn more about Biocytogen's comprehensive portfolio of oncology and immuno-oncology models.
What is Tumour Models Summit San Francisco?
This year’s Tumour Models Summit will celebrate 10 years of innovation and collaboration in tumour modeling. As new therapies emerge and regulations are reworked, there’s a growing demand for more advanced and predictive models. This conference will connect leaders across preclinical development, translational research, immuno-oncology, in vivo pharmacology and toxicology to drive growth and foster innovation in cancer research.
Event Overview
Date: January 28th - 29th, 2026
Venue: Hyatt Centric Fisherman's Wharf, 555 North Point St, San Francisco, CA 94133
Event Schedule
For more information, please refer to the Tumour Models Summit San Francisco agenda
About BIOCYTOGEN
Biocytogen is a global biotechnology company that drives the research and development of novel antibody-based drugs with innovative technologies. Founded on gene editing technology, Biocytogen leverages genetically engineered proprietary RenMice® platforms for fully human monoclonal antibody discovery, and has established a sub-brand, RenBiologics™, to explore global partnerships for an off-the-shelf library of >400,000 fully human antibody sequences against approximately 1000 targets for worldwide collaboration. Biocytogen pioneered the generation of drug target knock-in humanized models for preclinical research, and currently provides a few thousand off-the-shelf animal and cell models under the company's sub-brand, BioMice™, along with preclinical pharmacology and gene-editing services for clients worldwide. Headquartered in Beijing, Biocytogen has branches in China (Haimen Jiangsu, Shanghai), USA(Boston, San Francisco), and Germany (Heidelberg).
We look forward to meeting you in San Francisco, CA!
